Pfizer 2013 Annual Report Download - page 118

Download and view the complete annual report

Please find page 118 of the 2013 Pfizer annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 123

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123

Notes to Consolidated Financial Statements
Pfizer Inc. and Subsidiary Companies
2013 Financial Report
117
Significant Product Revenues
The following table provides revenues by product:
Year Ended December 31,
(MILLIONS OF DOLLARS) 2013 2012 2011(a)
Revenues from biopharmaceutical products:
Lyrica $ 4,595 $ 4,158 $ 3,693
Prevnar family 3,974 4,117 4,145
Enbrel (Outside the U.S. and Canada) 3,774 3,737 3,666
Celebrex 2,918 2,719 2,523
Lipitor(b) 2,315 3,948 9,577
Viagra 1,881 2,051 1,981
Zyvox 1,353 1,345 1,283
Norvasc 1,229 1,349 1,445
Sutent 1,204 1,236 1,187
Premarin family 1,092 1,073 1,013
BeneFIX 832 775 693
Vfend 775 754 747
Genotropin 772 832 889
Pristiq 698 630 577
Chantix/Champix 648 670 720
Refacto AF/Xyntha 602 584 506
Xalatan/Xalacom 589 806 1,250
Detrol/Detrol LA 562 761 883
Zoloft 469 541 573
Medrol 464 523 510
Effexor 440 425 678
Zosyn/Tazocin 395 484 636
Zithromax/Zmax 387 435 453
Fragmin 359 381 382
Relpax 359 368 341
Tygacil 358 335 298
Rapamune 350 346 372
Inlyta 319 100 —
Sulperazon 309 262 218
Revatio 307 534 535
Cardura 296 338 380
Xalkori 282 123 16
Xanax/Xanax XR 276 274 306
Diflucan 242 259 265
Toviaz 236 207 187
Aricept(c) 235 326 450
Inspra 233 214 195
Caduet 223 258 538
Somavert 217 197 183
Neurontin 216 235 289
Unasyn 212 228 231
BMP2 209 263 340
Geodon 194 353 1,022
Depo-Provera 191 148 139
Aromasin 185 210 361
Xeljanz 114 6—
Alliance revenues(d) 2,628 3,492 3,630
All other biopharmaceutical products 7,360 7,804 7,441
Total revenues from biopharmaceutical products 47,878 51,214 57,747
Other revenues:
Consumer Healthcare 3,342 3,212 3,028
Other(e) 364 231 260
Revenues $ 51,584 $ 54,657 $ 61,035